Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sabby Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$43M
Portfolio companies 13
Rounds per year 1.17
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.07
Exits 12
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Biopharma
  • Medical
Summary

The leading representative office of defined Corporate Investor is situated in the Upper Saddle River. The venture was found in North America in United States.

The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Sabby Capital, startups are often financed by Third Rock Ventures, New Enterprise Associates, Roche Venture Fund. The meaningful sponsors for the fund in investment in the same round are RA Capital Management, Perceptive Advisors, Rock Springs Capital. In the next rounds fund is usually obtained by Perceptive Advisors, Pontifax, Commercial Street Capital.

Among the most popular fund investment industries, there are Biopharma, Therapeutics. Among the various public portfolio startups of the fund, we may underline Epic Sciences, Arno Therapeutics, Stem Cell Therapeutics The fund has no exact preference in some founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Deals in the range of 50 - 100 millions dollars are the general things for fund. The high activity for fund was in 2014. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2015. This Sabby Capital works on 63 percentage points more the average amount of lead investments comparing to the other organizations.

We also calculated 1 valuable employee in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sabby Capital:
Typical Co-investors
Sabby Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sabby Capital:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alectra Canada, Mississauga, Ontario
Apsara Investments Central, Central Region, Singapore
Broadhaven Capital Partners New York, New York, United States
Godavari Biorefineries India, Maharashtra, Mumbai
Hack VC California, San Francisco, United States
Hengxu Capital -
Jumpstart-up -
Leap Wireless California, San Diego, United States
Mission Throttle Michigan, Southfield, United States
Moscar Capital England, London, United Kingdom
National Foundation -
Pegasus Capital Connecticut, Cos Cob, United States
River Hollow Partners New York, New York, United States
RPR Venture -
SARVA India, Maharashtra, Mumbai
Seek Ventures England, London, United Kingdom
Siebel Systems California, Redwood Shores, United States
Thuasne -
Yingxue Ziben China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cidara Therapeutics

Biotechnology
Health Care
Therapeutics
$42M11 Feb 2015 San Diego, California, United States

Global Blood Therapeutics

Biotechnology
Genetics
Medical
Therapeutics
$48M06 Jan 2015 San Francisco, California, United States

Naurex

Biopharma
Biotechnology
Therapeutics
$80M03 Dec 2014 Illinois, United States

Blueprint Medicines

Bioinformatics
Biotechnology
Health Care
Medical
$50M12 Nov 2014 Cambridge, Massachusetts, United States

Bellicum Pharmaceuticals

Biotechnology
Health Care
Health Diagnostics
Therapeutics
$55M27 Aug 2014 Houston, Texas, United States

Dermira

Biopharma
Biotechnology
Pharmaceutical
$51M19 Aug 2014 California, United States

Adverum Biotechnologies

Biotechnology
Pharmaceutical
Therapeutics
$55M22 Apr 2014 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sabby Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 14
Average round size 43M
Rounds per year 1.17
Peak activity year 2015
Lead investments 0
Follow on index 0.07
Exits 12
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Cidara Therapeutics

Biotechnology
Health Care
Therapeutics
$42M11 Feb 2015 San Diego, California, United States

Global Blood Therapeutics

Biotechnology
Genetics
Medical
Therapeutics
$48M06 Jan 2015 San Francisco, California, United States

Naurex

Biopharma
Biotechnology
Therapeutics
$80M03 Dec 2014 Illinois, United States

Blueprint Medicines

Bioinformatics
Biotechnology
Health Care
Medical
$50M12 Nov 2014 Cambridge, Massachusetts, United States

Bellicum Pharmaceuticals

Biotechnology
Health Care
Health Diagnostics
Therapeutics
$55M27 Aug 2014 Houston, Texas, United States

Dermira

Biopharma
Biotechnology
Pharmaceutical
$51M19 Aug 2014 California, United States

Adverum Biotechnologies

Biotechnology
Pharmaceutical
Therapeutics
$55M22 Apr 2014 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: